Ligand Receiving $500,000 Payment From Glaxo
Stock quotes in this article:
LGND
NEW YORK (AP) — Ligand Pharmaceuticals Inc. said it will receive a $500,000 payment from GlaxoSmithKline as part of a research deal amendment from 2006.
The deal involves a program focusing on potential treatments for inflammatory conditions. Ligand said it has already earned $4 million from GlaxoSmithKline under the deal. San Diego-based Ligand had revenue of $27.3 million in 2008.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |
